Literature DB >> 20004965

Fighting overtreatment in adjuvant breast cancer therapy.

Michael Gnant1, Guenther G Steger2.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20004965     DOI： 10.1016/S0140-6736(09)62097-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists.

Authors:  M A O'Brien; S Dhesy-Thind; C Charles; M Hammond Mobilio; N B Leighl; E Grunfeld
Journal:  Curr Oncol       Date:  2017-04-27       Impact factor: 3.677

2.  Gene signatures in breast cancer: current and future uses.

Authors:  Enrique Espinosa Arranz; Juan Ángel Fresno Vara; Angelo Gámez-Pozo; Pilar Zamora
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

3.  Modern therapeutic concepts of early breast cancer.

Authors:  Michael Gnant
Journal:  Breast Care (Basel)       Date:  2014-05       Impact factor: 2.860

4.  Guidelines: usefulness and limitations.

Authors:  Michael Gnant
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

5.  Women's perceptions of their involvement in treatment decision making for early stage breast cancer.

Authors:  Mary Ann O'Brien; Cathy Charles; Timothy J Whelan; Peter M Ellis; Amiram Gafni; Peter Lovrics
Journal:  Support Care Cancer       Date:  2013-01-24       Impact factor: 3.603

Review 6.  Molecular profiling for breast cancer: a comprehensive review.

Authors:  Muaiad Kittaneh; Alberto J Montero; Stefan Glück
Journal:  Biomark Cancer       Date:  2013-10-29

7.  EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.

Authors:  P Dubsky; M Filipits; R Jakesz; M Rudas; C F Singer; R Greil; O Dietze; I Luisser; E Klug; R Sedivy; M Bachner; D Mayr; M Schmidt; M C Gehrmann; C Petry; K E Weber; R Kronenwett; J C Brase; M Gnant
Journal:  Ann Oncol       Date:  2012-10-03       Impact factor: 32.976

Review 8.  Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine.

Authors:  Kamil A Lipinski; Louise J Barber; Matthew N Davies; Matthew Ashenden; Andrea Sottoriva; Marco Gerlinger
Journal:  Trends Cancer       Date:  2016-01-29

9.  Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer.

Authors:  Sungmin Park; Se Kyung Lee; Hyun-June Paik; Jai Min Ryu; Isaac Kim; Soo Youn Bae; Jonghan Yu; Seok Won Kim; Jeong Eon Lee; Seok Jin Nam
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

10.  The Value of Monitoring the Behavior of Circulating Tumor Cells at the End of Endocrine Therapy in Breast Cancer Patients.

Authors:  Katharina Pachmann; Stefan Schuster
Journal:  Cancers (Basel)       Date:  2018-10-29       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.